As per this new research survey by Fact.MR, the transfer membrane market is set to exhibit a sluggish CAGR of 1.7% from 2022 to 2032. Currently, the global market holds a net worth of US$ 191.1 million.
The world has witnessed a prominent increase in the prevalence of chronic and infectious diseases over the past few years, and this has propelled the demand for novel treatment therapies. Increasing investments in research and development to meet the high demand for novel drugs and therapies are expected to drive demand for transfer membranes through 2032. Key transfer membrane providers are expected to focus on mergers, collaborations, partnerships, and acquisitions to expand their business potential and gain a competitive edge over other transfer membrane companies.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7375
Key Takeaways from Market Study
- At present, the transfer membrane market stands at a net valuation of US$ 191.1 million.
- The market for transfer membranes is predicted to expand at a CAGR of 1.7% from 2022 to 2032.
- The transfer membrane market is anticipated to reach a valuation of US$ 226.3 million by 2032.
- Increasing investments in R&D, supportive government initiatives, and growing prevalence of chronic diseases are expected to be major factors driving transfer membrane market potential across the forecast period.
- Lack of skilled healthcare professionals and the availability of alternative methods are expected to constrain transfer membrane market growth.
- The North America transfer membrane market is projected to maintain its dominant market share and account for US$ 78.8 million by 2032.
- Demand for PVDF transfer membranes is projected to rise at a CAGR of 1.9% and reach US$ 125.9 million by 2032.
“Rising prevalence of chronic diseases and increasing investments in related research & development will drive transfer membrane market potential,” says a Fact.MR analyst
This is attributable to an increase in the prevalence of coronary artery disease among low-income group people and an increase in the expense of postoperative intensive care units at hospitals.
Market Imperative
Key transfer membrane suppliers are focusing on strengthening their market presence by promoting and pushing the sales of their most effective products. Products such as 3M gas transfer membranes, BioTrace NT nitrocellulose transfer membranes, and Bio-Rad PVDF transfer membranes are expected to be highly popular in the global market.
Transfer membrane vendors are focusing on launching new products and expanding their product portfolios to gain dominance in the moderately fragmented marketplace.
Market Titans
- ATTO Corporation
- Axiva Sichem Biotech
- GE Healthcare
- Merck KGaA
- PerkinElmer Inc.
- Santa Cruz Biotechnology
- Macherey-Nagel
- Pall Corporation
- Thermo Fisher Scientific
- Bio-Rad Laboratories Inc
Winning Strategy
Transfer membrane manufacturers are deploying various organic and inorganic strategies to increase their market presence and boost revenue generation. Transfer membrane vendors are also focusing on developing new technologies to further advance membrane technologies and create efficient solutions for various end uses.
Various medical device manufacturing businesses have headquarters and manufacturing units in different countries, which might cause a demand-supply imbalance for the global bioabsorbable stent market share.
Industry Research
-
by Type:
- PVDF Transfer Membranes
- Nitrocellulose Transfer Membranes
- Nylon Transfer Membranes
-
by End Use:
- Academic & Research
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Uses
-
by Region:
- North America
- Latin America
- Europe
- APAC
- MEA
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global transfer membrane market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032.
The study divulges essential insights on the market on the basis of type (PVDF, nitrocellulose, nylon) and end use (academic & research, pharmaceutical & biotechnology companies, diagnostic laboratories, other end uses), across five major regions (North America, Latin America, Europe, APAC, and the MEA).
Get Customization on this Market for Specific Research Solutions at
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7375
